COMMUNIQUÉS West-GlobeNewswire

First Steroid Cycle: Best Steroids for Muscle Growth (Before And After Result), Steroids for Beginners - By CrazyBulk USA
16/05/2025
New York City, NY, May 16, 2025 (GLOBE NEWSWIRE) -- Initiating the first steroid cycle as a new bodybuilder may be thrilling yet terrifying. Despite all the information and diverse counsel obtainable over the internet, [...]
Thyroid Support Under Review: Best Thyroid Support Supplements For Thyroid Health & Healthy Thyroid Hormone Production
16/05/2025
Looking for the best thyroid support supplement in 2025? Discover how Thyroid Support helps improve thyroid health, hormonal balance, energy, and focus — naturally. Richmond, Virginia, May 16, 2025 (GLOBE NEWSWIRE) -- [...]
Shape Therapeutics Presents Preclinical Data Highlighting Therapeutic Potential of RNA Editing and AAV Delivery Platforms at the American Society of Gene and Cell Therapy 28th Annual Meeting
16/05/2025
Industry-leading RNA editing activity in the CNS of both mice and non-human primates highlights the broad applicability and therapeutic potential of the RNAfix ® platform in CNS diseases Preclinical data showcases first [...]
Bruno Male Enhancement Australia Legal Alternatives: 2025 User Discover the Biggest Read Bruno Chemist Warehouse Reviews
16/05/2025
Bruno Male Enhancement has summarized all the health benefits altogether. With the essence of natural ingredients, men have lost their manhood. This perfect blend of natural ingredients makes your overall health smooth [...]
Arialief Under Review: The Truth About Arialief and the Nerve Relief Trick
16/05/2025
Arialief’s 7-Second Nerve Relief Trick Sparks a Holistic Neuropathy Craze—Science-Backed Formula Calms Inflammation and Restores Nerve Comfort with Each Daily Dose AURORA, Colo., May 16, 2025 (GLOBE NEWSWIRE) -- What [...]
Merus annonce la publication d’un article sur le mécanisme d’action du pétosemtamab
16/05/2025
UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 16 mai 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), ci-après « Merus », « la Société », « nous » ou « notre/nos », une société d’oncologie au stade clinique [...]
Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement
16/05/2025
GERMANTOWN, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose [...]
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
16/05/2025
SOUTH SAN FRANCISCO, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative [...]
Ancient Biblical Remedies Under Review: Ancient Lost Remedies Revived with Hidden Healing Secret Remedies of the Scriptures
16/05/2025
365 Daily Health Unveils “The Encyclopedia of Natural Remedies” — A Faith-Based Digital Guide Reviving Ancient Biblical Remedies with Over 100 Scripture-Inspired Healing Practices for Holistic Wellness, Spiritual [...]
FuturHealth Under Review: Best GLP-1 Semaglutide Medication Prescription for Weight Loss with No Insurance
16/05/2025
Discover How FuturHealth’s Affordable Semaglutide Subscription Program Helps Users Lose Weight Without Insurance, Prescriptions, or Hassle—A Game-Changer in the GLP-1 Weight Loss Revolution San Diego, May 15, 2025 ( [...]
HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results
16/05/2025
MIRAMAR, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel [...]
Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy
16/05/2025
TEL AVIV, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals (NYSE and TASE: TEVA) today announced that Moody's Investor Services (“Moody's”) has raised the company's corporate credit rating to Ba1, outlook [...]
BioSyent Releases Financial Results for First Quarter 2025
15/05/2025
MISSISSAUGA, Ontario, May 15, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the first quarter (Q1) ended March 31, 2025. Key highlights include: (CAD) Q1 [...]
BioSyent Declares Second Quarter 2025 Dividend
15/05/2025
MISSISSAUGA, Ontario, May 15, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.05 per common [...]
Biofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business Update
15/05/2025
Conference call begins at 10:00 a.m. Eastern time on Friday, May 16, 2025 WOBURN, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the [...]
Shuttle Pharma Provides Corporate Update
15/05/2025
GAITHERSBURG, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused [...]
Rakovina Therapeutics Announces Strategic Private Placement, Convertible Debt Financing, and Share Consolidation to Accelerate US-Focused Growth and AI-Powered Oncology Innovation
15/05/2025
$3 Million Lead Order from Strategic Investors Supports Bold Transformation VANCOUVER, British Columbia, May 15, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“ Rakovina ” or the “ Company [...]
60 Degrees Pharmaceuticals Announces First Quarter 2025 Results
15/05/2025
Q1 2024 net product revenues increased 55% year-over-year to $163.6 thousand. Gross profit increased 124% to $90.3 thousand. WASHINGTON, May 15, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP ; [...]
Globus Medical Announces $500 Million Share Repurchase Program
15/05/2025
AUDUBON, Pa., May 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors has authorized a share repurchase program of up [...]

Pages